Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised controlled trial comparing the efficacy, safety and cost-effectiveness of transurethral resection (TURP), laser vaporisation (LVAP), transurethral needle ablation (TUNA) and microwave thermoablation (MTA) of the prostate
ISRCTN ISRCTN23921450
ClinicalTrials.gov identifier
Public title A randomised controlled trial comparing the efficacy, safety and cost-effectiveness of transurethral resection (TURP), laser vaporisation (LVAP), transurethral needle ablation (TUNA) and microwave thermoablation (MTA) of the prostate
Scientific title
Acronym N/A
Serial number at source HTA 94/04/08
Study hypothesis 50% of men over 60 years will experience symptoms attributable to benign prostatic enlargement (BNE). The traditional treatment of TURP is efficacious but carries a mortality of 0.5-1% rising to 8% in the over 80s. The overall morbidity is around 80% and has significant implications for quality of life following surgery. The proposed RCT will comprehensively compare the four surgical options TURP, LVAP TUNA and MTA in terms of efficacy, morbidity, cost and overall health gain. The evidence will be used to examine the relative efficiency of each alternative. Clinicians and purchasers of health care need the results of such analyses before deciding whether or not to invest finite resources in newer treatments.
Lay summary
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Benign prostatic enlargement (BNE)
Participants - inclusion criteria Men over 60 years
Participants - exclusion criteria Not provided at time of registration.
Anticipated start date 01/06/1996
Anticipated end date 31/05/1999
Status of trial Stopped
Patient information material
Target number of participants Not provided at time of registration.
Interventions Please note that this trial was terminated due to poor recruitment.

A comparison of the 4 surgical options: TURP, LVAP, TUNA and MTA
Primary outcome measure(s) Efficacy, morbidity, cost and overall health gain.
Secondary outcome measure(s) Not provided at time of registration.
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications
Contact name Mr  Chris  Chapple
  Address Department of Urology
Central Sheffield University Hospitals NHS Trust
Royal Hallamshire Hospital
Glossop Road
  City/town Sheffield
  Zip/Postcode S10 2JF
  Country United Kingdom
  Tel +44 (0)114 2712559/3047
  Fax +44 (0)114 279 8318
  Email c.r.chapple@shef.ac.uk
Sponsor Department of Health (UK)
  Address Quarry House
Quarry Hill
  City/town Leeds
  Zip/Postcode LS2 7UE
  Country United Kingdom
  Tel +44 (0)1132 545 843
  Email Sheila.Greener@doh.gsi.gov.uk
  Sponsor website: http://www.dh.gov.uk/en/index.htm
Date applied 25/04/2003
Last edited 14/10/2009
Date ISRCTN assigned 25/04/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central